(Q38108208)

29 August 2017

Charged particle therapy--optimization, challenges and future directions (English)

1 reference

29 August 2017

2

1 reference

29 August 2017

Jay S Loeffler

1

1 reference

PubMed ID

23689752

29 August 2017

language of work or name

English

0 references

publication date

21 May 2013

1 reference

Nature Reviews Clinical Oncology

29 August 2017

1 reference

29 August 2017

10

1 reference

29 August 2017

7

1 reference

29 August 2017

411-424

1 reference

https://scigraph.springernature.com/pub.10.1038/nrclinonc.2013.79

29 August 2017

0 references

cites work

Past, present, and future of radiotherapy for the benefit of patients

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Image-guided radiotherapy: from current concept to future perspectives

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

IMRT: a review and preview

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Stereotactic body radiation therapy: a novel treatment modality

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

The expanding roles of stereotactic body radiation therapy and oligofractionation: toward a new practice of radiotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Charged particles in radiation oncology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Impact of enhancements in the local effect model (LEM) on the predicted RBE-weighted target dose distribution in carbon ion therapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Charged particles in radiotherapy: a 5-year update of a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Eighth Warren K. Sinclair Keynote Address

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Results of heavy ion radiotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

An evidence based review of proton beam therapy: the report of ASTRO's emerging technology committee.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Dose-volume comparison of proton therapy and intensity-modulated radiotherapy for prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Radiation Therapy Modalities for Prostate Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Radiation Therapy Modalities for Prostate Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Results of a multicentric in silico clinical trial (ROCOCO): comparing radiotherapy with photons and protons for non-small cell lung cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Proton therapy in clinical practice: current clinical evidence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Particle radiation therapy using proton and heavier ion beams

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Current clinical evidence for proton therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Systematic review: charged-particle radiation therapy for cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

A review of update clinical results of carbon ion radiotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Clinical evidence of particle beam therapy (proton).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

31 March 2020

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Assessing the risk of second malignancies after modern radiotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Prospective study of health-related quality of life for children with brain tumors treated with proton radiotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Late effects in the era of modern therapy for Hodgkin lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Rationale for and preliminary results of proton beam therapy for mediastinal lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Carbon ion radiotherapy for pediatric patients and young adults treated for tumors of the skull base

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Treatment of pediatric patients and young adults with particle therapy at the Heidelberg Ion Therapy Center (HIT): establishment of workflow and initial clinical data

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Risk of second cancers after photon and proton radiotherapy: a review of the data

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Comparison of risk of radiogenic second cancer following photon and proton craniospinal irradiation for a pediatric medulloblastoma patient

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Assessment of the risk for developing a second malignancy from scattered and secondary radiation in radiation therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Modeling intracranial second tumor risk and estimates of clinical toxicity with various radiation therapy techniques for patients with pituitary adenoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Cancer risks attributable to low doses of ionizing radiation: Assessing what we really know

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Assessing cancer risks of low-dose radiation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Computed Tomography — An Increasing Source of Radiation Exposure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Intensity-modulated radiation therapy, protons, and the risk of second cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Out-of-field dose measurements in a water phantom using different radiotherapy modalities

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Out-of-field dose studies with an anthropomorphic phantom: Comparison of X-rays and particle therapy treatments

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Heavy ion radiotherapy during pregnancy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Particle therapy and treatment of cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Long-term results of carbon ion radiation therapy for locally advanced or unfavorably located choroidal melanoma: usefulness of CT-based 2-port orthogonal therapy for reducing the incidence of neovascular glaucoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Progress in radiotherapy for pediatric sarcomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Locoregional treatment for adult soft tissue sarcomas of the head and neck: an institutional review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Proton-based radiotherapy for unresectable or incompletely resected osteosarcoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Impact of carbon ion radiotherapy for unresectable osteosarcoma of the trunk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Effect of carbon ion radiotherapy for sacral chordoma: results of Phase I-II and Phase II clinical trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Clinical outcome of sacral chordoma with carbon ion radiotherapy compared with surgery.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Randomised trial of proton vs. carbon ion radiation therapy in patients with chordoma of the skull base, clinical phase III study HIT-1-Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Randomised trial of proton vs. carbon ion radiation therapy in patients with low and intermediate grade chondrosarcoma of the skull base, clinical phase III study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Comparison of intensity-modulated radiotherapy, adaptive radiotherapy, proton radiotherapy, and adaptive proton radiotherapy for treatment of locally advanced head and neck cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

The potential benefit of radiotherapy with protons in head and neck cancer with respect to normal tissue sparing: a systematic review of literature

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Systematic review and meta-analysis of radiotherapy in various head and neck cancers: comparing photons, carbon-ions and protons.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Therapy strategies for locally advanced adenoid cystic carcinomas using modern radiation therapy techniques

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

New advances that enable identification of glioblastoma recurrence.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Phase I/II trial of hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: the CLEOPATRA trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

A restricted cell population propagates glioblastoma growth after chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Irradiation of the potential cancer stem cell niches in the adult brain improves progression-free survival of patients with malignant glioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Evaluation of high ipsilateral subventricular zone radiation therapy dose in glioblastoma: a pooled analysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Can irradiation of potential cancer stem-cell niche in the subventricular zone influence survival in patients with newly diagnosed glioblastoma?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Hepatocellular carcinoma biology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

31 March 2020

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

High-dose proton beam radiotherapy of hepatocellular carcinoma: preliminary results of a phase II trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Comparison of efficacy and toxicity of short-course carbon ion radiotherapy for hepatocellular carcinoma depending on their proximity to the porta hepatis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Phase i study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: the PROMETHEUS-01 trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Advanced pancreatic carcinoma: current treatment and future challenges

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

A phase I/II study of gemcitabine-concurrent proton radiotherapy for locally advanced pancreatic cancer without distant metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Phase 1 trial of preoperative, short-course carbon-ion radiotherapy for patients with resectable pancreatic cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

A 10-year experience of total pelvic exenteration for primary advanced and locally recurrent rectal cancer based on a prospective database

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Cost-effectiveness of carbon ion radiation therapy for locally recurrent rectal cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Phase I/II trial evaluating carbon ion radiotherapy for the treatment of recurrent rectal cancer: the PANDORA-01 trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

New insights into the management of renal cell cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Carbon ion radiation therapy for primary renal cell carcinoma: initial clinical experience.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

31 March 2020

Ion beam therapy in 2004

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Proton versus intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Patient-reported long-term outcomes after conventional and high-dose combined proton and photon radiation for early prostate cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate cancer: results of two prospective trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Proton beam radiation therapy for prostate cancer-is the hype (and the cost) justified?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Meta-analysis of the alpha/beta ratio for prostate cancer in the presence of an overall time factor: bad news, good news, or no news?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Toward optimal external-beam fractionation for prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Carbon-ion radiation therapy for prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB non-small-cell lun

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Hypofractionation in radiotherapy. An investigation of injured Swedish women, treated for cancer of the breast

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Hypofractionated radiation therapy in the treatment of early-stage breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Modern hypofractionation schedules for tangential whole breast irradiation decrease the fraction size-corrected dose to the heart.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Partial breast irradiation delivered with proton beam: results of a phase II trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Particle therapy for noncancer diseases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Bragg-Peak Proton-Beam Therapy for Arteriovenous Malformations of the Brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Dose-volume prediction of radiation-related complications after proton beam radiosurgery for cerebral arteriovenous malformations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Proton stereotactic radiosurgery for the treatment of benign meningiomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Radiation therapy in the management of pituitary adenomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Cyberknife radiosurgery in treating trigeminal neuralgia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Radiation therapy for neovascular age-related macular degeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Systematic review: comparative effectiveness of radiofrequency catheter ablation for atrial fibrillation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

The European Society of Therapeutic Radiology and Oncology-European Institute of Radiotherapy (ESTRO-EIR) report on 3D CT-based in-room image guidance systems: a practical and technical review and guide.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Motion in radiotherapy: photon therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Motion in radiotherapy: particle therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Applications of particle accelerators in medicine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Curative treatment of Stage I non-small-cell lung cancer with carbon ion beams using a hypofractionated regimen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Motion mitigation in intensity modulated particle therapy by internal target volumes covering range changes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Special report: Workshop on 4D-treatment planning in actively scanned particle therapy-Recommendations, technical challenges, and future research directions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Real-time tumour tracking in particle therapy: technological developments and future perspectives.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Proton range verification using a range probe: definition of concept and initial analysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Systematic analysis of RBE and related quantities using a database of cell survival experiments with ion beam irradiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Relative biological effectiveness (RBE) values for proton beam therapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Application of constant vs. variable relative biological effectiveness in treatment planning of intensity-modulated proton therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Exploring the role of cancer stem cells in radioresistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Hypoxia-inducible factors, stem cells, and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Overcoming resistance of cancer stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Interactions between cancer stem cells and their niche govern metastatic colonization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Effects of carbon ion beam on putative colon cancer stem cells and its comparison with X-rays

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Different effects of carbon ion beams and X-rays on clonogenic survival and DNA repair in human pancreatic cancer stem-like cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Tumor response to radiotherapy regulated by endothelial cell apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Ceramide biogenesis is required for radiation-induced apoptosis in the germ line of C. elegans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

In vitro evaluation of photon and carbon ion radiotherapy in combination with chemotherapy in glioblastoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Immunotherapy of cancer in 2012.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

The controversial abscopal effect

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Immunologic correlates of the abscopal effect in a patient with melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Abscopal effect in a patient with melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Enhancement of antitumor radiation efficacy and consistent induction of the abscopal effect in mice by ECI301, an active variant of macrophage inflammatory protein-1alpha

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Systemic effects of local radiotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Combining radiotherapy and cancer immunotherapy: a paradigm shift

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Carbon ion irradiation suppresses metastatic potential of human non-small cell lung cancer A549 cells through the phosphatidylinositol-3-kinase/Akt signaling pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Carbon-ion beam treatment induces systemic antitumor immunity against murine squamous cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Imaging hypoxia to improve radiotherapy outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.79

Particle irradiation suppresses metastatic potential of cancer cells.

31 March 2020

1 reference

12 December 2020

The use of neutrons in cancer therapy: a historical perspective through the modern era.

1 reference

12 December 2020

Proton therapy for prostate cancer

1 reference

12 December 2020

Radiotherapy targeting cancer stem cells: current views and future perspectives.

1 reference

12 December 2020

Heavy ion irradiation inhibits in vitro angiogenesis even at sublethal dose.

1 reference

12 December 2020

Re: Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer

1 reference

12 December 2020

Proton radiosurgery in neurosurgery

1 reference

12 December 2020

Improving the therapeutic ratio in Hodgkin lymphoma through the use of proton therapy.

1 reference

12 December 2020

10.1038/NRCLINONC.2013.79

Identifiers

DOI

1 reference

PubMed ID

23689752

Dimensions Publication ID

29 August 2017

0 references

1 reference

PubMed ID

23689752